News
Ketamine beats midazolam for agitation control
SAN DIEGO – In recent years, ketamine has become a popular drug in emergency medical services for the control of agitation.
News
Point-of-care test for respiratory viruses lowers antibiotic use
PARIS – In patients presenting with respiratory infections, a point-of-care test for viral infections has been associated with a reduction in...
News
Troponin I: Powerful all-cause mortality risk marker in COPD
PARIS – The relationship between increased troponin I and increased all-cause mortality was observed in an on-going prospective multicenter cohort...
News
Global bronchial thermoplasty registry for asthma documents benefits
A global registry showed that an improvement in quality of life 1 year after bronchothermoplasty was accompanied by reductions in exacerbations....
News
Sildenafil added to nintedanib offers no benefit in IPF patients
PARIS – A randomized trial found that the addition of sildenafil to nintedanib was not associated with a significant clinical benefit.
News
Dupilumab efficacy extends to chronic rhinosinusitis/nasal polyposis
PARIS – Post hoc analysis of phase 3 trial data looked at the efficacy dupilumab in preventing asthma exacerbations in patients with chronic...
News
Azithromycin for COPD exacerbations may reduce treatment failure
PARIS – Started when patients with COPD are hospitalized for an exacerbation, a 90-day course of azithromycin improved multiple outcome measures...
News
Guideline: PFO closure best bet for recurrent stroke prevention
Although a “weak” recommendation, PFO closure is named as the preferred therapy for reducing risk of recurrent stroke.
News
Mandated 1-hour sepsis care protocol lowers mortality in children
Results from a New York study support a protocol approach to sepsis management in children.
News
Limited anakinra course often enough for systemic JIA if used first
AMSTERDAM – About two-thirds of children with JIA remained in remission after 5 years when a 3-month course of the IL-1 receptor antagonist...
News
In JIA, etanercept associated with lower uveitis risk compared with methotrexate
AMSTERDAM – In contrast to several previous reports, a new study associated etanercept with a low relative risk of uveitis in children with JIA....
News
Data suggest harm outweighs benefit of opioids for musculoskeletal pain
AMSTERDAM – There is little if any good quality evidence that opioids offer benefit in the treatment of pain related to osteoarthritis or other...
